Lipella Pharmaceuticals Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,185 | 3,294 | 5,122 | 1,414 | 607 |
| Marketable Securities | N/A | N/A | N/A | 301 | N/A |
| Receivables | 85 | 32 | 114 | N/A | 69 |
| TOTAL | $2,617 | $3,429 | $5,799 | $1,808 | $699 |
| Non-Current Assets | |||||
| PPE Net | 10 | 13 | N/A | N/A | N/A |
| Other Non-Current Assets | 47 | 135 | 151 | 205 | 256 |
| TOTAL | $57 | $148 | $151 | $205 | $256 |
| Total Assets | $2,674 | $3,577 | $5,950 | $2,013 | $955 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 250 | 25 | 78 |
| Accounts payable and accrued liabilities | 388 | 138 | 384 | 47 | 25 |
| Accrued Expenses | 238 | 77 | 389 | 152 | N/A |
| Other current liabilities | 81 | 81 | 71 | 78 | 52 |
| TOTAL | $754 | $385 | $1,178 | $341 | $208 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 50 | 50 |
| Other Non-Current Liabilities | 0 | 47 | 96 | 199 | 234 |
| TOTAL | $N/A | $47 | $96 | $249 | $284 |
| Total Liabilities | $754 | $433 | $1,275 | $589 | $492 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,549 | 781 | N/A | N/A | N/A |
| Common Shares | 0 | 0 | 1 | 0 | 1 |
| Retained earnings | -15,340 | -10,324 | -5,705 | -3,107 | -1,242 |
| TOTAL | $1,920 | $3,144 | $4,676 | $1,424 | $463 |
| Total Liabilities And Equity | $2,674 | $3,577 | $5,950 | $2,013 | $955 |